Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
What to Expect in Month 3 Nausea improvement: Drops from constant/frequent to occasional/rare for most patients Energy returns: As your body adjusts to new eating patterns and medication Appetite normalization: Still suppressed (therapeutic effect) but more predictable Weight loss becomes visible: Average 8-10% by week 12, friends and family notice Confidence builds: Youve survived the worst, know you can continue 4 Strategies for Month 3 11
If Phase 3 trials complete successfully and Lilly submits an NDA in late this year, FDA approval could come by mid to late next year
Fast-Absorbing Liquid Formula Superior bioavailability for quicker results
According to SUCRA values, the top two ranked administration routes were the oral route (78.3) followed by the IM route (49.6) (Table 3(B))
& Borges, N
